Integra LifeSciences, Premier Ink 3-Year Purchase Deal - Analyst Blog

By
A A A

The Orthopedics and Tissue Technologies group of Integra LifeSciences Holding Corporation ( IART ) has recently signed a 3-year group purchasing contract with Charlotte, N.C.-based healthcare improvement company Premier, Inc.

Per the contract, Integra will offer small bone orthopedic implants to patients of Premier alliance member healthcare organizations. However, following this seemingly positive news, Integra's share price dropped marginally by 0.9% on Friday.

Per management at Integra, this deal seeks to establish a long-lasting relationship between the two healthcare organizations. Integra expects this contract to help it provide Premier members with the best-in-class products and services aimed at serving upper and lower extremity patients.


This new agreement will allow Integra to meet Premier's needs for orthopedic devices. The deal will also ensure greater access to Integra's entire portfolio, the benefits of which can be reaped by Premier alliance healthcare members.

This marks the initial step in Integra's Enterprise selling efforts to develop larger enterprise contracts to support the company's growth plans over the next 5 years. The pact with Premier is also significant as it represents the company's first agreement of this kind.

The abovementioned deal is well poised to contribute substantially to Integra's Extremities business in 2015 and beyond. However, management expects it to have no significant impact on the company's 2014 financial results.

New Jersey-based Integra is a leading provider of surgical instruments and a manufacturer of orthobiologic products for repair and grafting of bones. The company develops small bone orthopedic implants for treatment of patients with common degenerative conditions impacting the upper and lower extremities at more than 5,200 hospitals and surgery centers in the U.S.

Integra currently has a Zacks Rank #4 (Sell). Some better-ranked stocks worth considering in the biomedical industry include ANI Pharmaceuticals, Inc. ( ANIP ), Gilead Sciences Inc. ( GILD ) and Illumina Inc. ( ILMN ). All these stocks carry a Zacks Rank #1 (Strong Buy).


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

ILLUMINA INC (ILMN): Free Stock Analysis Report

INTEGRA LIFESCI (IART): Free Stock Analysis Report

GILEAD SCIENCES (GILD): Free Stock Analysis Report

ANI PHARMACEUT (ANIP): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: Investing , Business , Stocks

Referenced Stocks: ILMN , IART , GILD , ANIP

Zacks.com

Zacks.com

More from Zacks.com:

Related Videos

Stocks

Referenced

Most Active by Volume

33,110,376
  • $113.99 ▲ 1.77%
25,034,179
    $17.98 unch
24,486,872
  • $7.41 ▲ 2.07%
20,864,535
  • $7.39 ▼ 2.76%
18,600,501
  • $8.30 ▼ 0.36%
17,530,211
  • $8.14 ▲ 3.17%
17,299,208
  • $93.79 ▲ 2.74%
14,669,760
  • $25.78 ▼ 0.19%
As of 12/26/2014, 04:15 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com